Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Parallel Session 3408

Neuron-glial Interplay in a-synucleinopathies: Mechanisms of Progression and Therapeutic Targets

Sunday, September 29, 2024
15:00 - 17:00 | Meeting Room 107 AB, Ground Level
Basic Science, Translational

In this session, the faculty will discuss the current evidence of neuron-glia interactions in a-synucleinopathies and the treatments targeting glia in mitigating neurodegeneration.

Kelvin Luk, USA
Wassilios Meissner, France


Evidence from Genetics
Mark Cookson, USA

Targets for Microglia and Astrocyte-Based Treatments in Parkinson’s Disease
Valina Dawson, USA

Targets for Glia-based Treatments in MSA
Nadia Stefanova, Austria

CSPC Liaisons:
Chin-Hsien Lin, Taiwan

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Discuss evidence from human genetics suggesting a causal role of neuron-glial interplay in a-synucleinopathies
  2. Discuss the current microglia-and astrocyte-targeted treatments for Parkinson’s disease
  3. Discuss the current glial-targeted treatments for multiple system atrophy

Recommended Audience
Fellow / Resident / Student
Researcher / Basic Science

Education Level
Experienced / Intermediate
Expert / Advanced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice